Vampires are basically immortal and run for cover when the “Sunpeaks”. Similar to the immortality of legendary vampires, the penny stock pump on Sunpeaks Ventures Inc. (OTC: SNPK) just won’t seem to die. Two days after the inevitable dump occurred where the stock price went from 0.825 to as low as 0.24 in the last trading session, questions are still flying around on whether the news released yesterday is a good reason to buy or a chance to sell at a higher price. SNPK announced that radio ads for Clotamin are about to commence in the Washington, D.C. area.
Shares of SNPK closed at 0.265, down -25.14%, on volume of 44,362,566 shares, $13,791,562 worth, with 4,367 executed trades in the last trading session. The radio ads is a new announcement for the Company through their subsidiary, Healthcare Distribution Specialists who entered into an advertising agreement with Pulse Advertising LLC.
Looking for Penny Stock Alerts? Subscribe and get our next penny stock picks FREE.
SNPK Stock Chart:
Market Capitalization: 148.86M
Shares Outstanding: 420.50M
52 Week High
52 Week Low
The “Clotamin” radio campaign is expected to run a total of 132 recorded 30-second advertisements, including 92 guaranteed prime “drive time” plays and 40 additional plays (5am – midnight) to be aired over a 4 week period starting May 15th, 2012 on WTOP-FM, an all-news radio station serving the Metropolitan Washington, DC area. It makes sense that after having successfully dumped their penny stock, SNPK, Sunpeaks Ventures’ CEO, CFO Mackie Barch, would join forces to run a radio advertising campaign for Clotamin in on of the poorest cities in the U.S.
FACT: Since SNPK made its penny stock debut on the OTC market on March 8th of this year, 1,126,368,630 shares have transacted. Using the LOD (Low Of the Day) as a measuring stick, $772,119,217 in dollar volume of SNPK has changed hands in buy – sell transactions on the penny stock.
$772M! And that’s using the LOD!
To put that into perspective; $2,075,852,449 was the total dollar volume on the OTCBB for the month of April, 2012.
Sunpeaks Ventures Inc., and its wholly owned subsidiary Healthcare Distribution Specialists, LLC, is a nationally focused, value-added distributor of specialty drugs and over-the-counter branded multivitamins to the healthcare provider market. Healthcare Distribution Specialists, LLC also owns and markets Clotamin, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin, a popular blood thinner that has a long list of known adverse drug and food interactions.
Bottom Line: The penny stock of Sunpeaks Ventures, as we said on March 8th, is SNPK now one of the OTC stocks to buy? Check North Springs Resources (NSRS) and how it has performed after the “official” dump.